Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors
Launched by UNIVERSITY OF WASHINGTON · Jul 15, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best timing for a computerized cognitive training program designed for older adults who have spent time in the intensive care unit (ICU). Many ICU survivors, especially those aged 60 and older, face challenges with thinking and memory after their hospital stay, often due to sleep problems and changes in their body’s natural rhythms. The trial aims to find out if morning or late afternoon/evening sessions of this cognitive training can help improve thinking skills better than standard care, as well as to understand the best time to provide this training for the best results.
To participate in this trial, you need to be at least 60 years old and have spent at least one day in the ICU. You should have been independent before your hospital stay and be able to speak English. If you have a history of certain serious conditions like Alzheimer’s or severe mental health issues, you won't be eligible. Participants will engage in training sessions and may receive personalized support to help improve their cognitive function. This study is currently recruiting participants at the University of Washington Medical Center, and your involvement could help shape better care for older ICU survivors in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 60 years
- • ICU length of stay ≥ 24 hours
- • Active transfer order or expected discharge from ICU to a post-ICU unit
- • Fluent in English
- • Functional independence prior to hospital admission (Katz Index = 6)
- • No suspicion of Alzheimer's disease/dementia
- • Current hospitalization at University of Washington Medical Center or Harborview Medical Center
- Exclusion Criteria:
- • Documented history or suspicion of Alzheimer's disease/dementia, or current prescription of anti-dementia medication
- • Documented history of bipolar disorder or schizophrenia
- • Documented acute stroke or acute traumatic brain injury
- • Severe visual impairment
- • Severe hearing impairment
- • Severe dominant arm paresis/paralysis
- • Transfer from inpatient rehabilitation or skilled nursing care facility
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Maya N Elias, PhD, MA, RN
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials